Opna Bio LLC: Clinical Trials

5 trials sponsored by Opna Bio LLC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated, 1 recruiting. 5 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 2, Terminated 2, Recruiting 1
Phase 22Terminated 2

Follow Opna Bio LLC: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma
OPN-6602, Dexamethasone - Relapsed Multiple Myeloma, Refractory Multiple Myeloma
Phase 1RecruitingOpna Bio LLC1302024-08-222026-10-30
PLX2853 in Combination With Abiraterone Acetate and Prednisone and in Combination With Olaparib in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
PLX2853 20 mg, Olaparib, Abiraterone acetate - Metastatic Castration-resistant Prostate Cancer
Phase 1 / Phase 2TerminatedOpna Bio LLC192020-09-212025-04-08
PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer
PLX2853, Carboplatin - Gynecologic Neoplasms, Epithelial Ovarian Cancer
Phase 1 / Phase 2TerminatedOpna Bio LLC372020-08-112024-11-04
A Study of PLX2853 in Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
PLX2853 - Relapsed Acute Myeloid Leukemia (AML), Refractory Acute Myeloid Leukemia (AML)
Phase 1CompletedOpna Bio LLC222019-03-192022-04-12
A Study of PLX2853 in Advanced Malignancies.
PLX2853 - Small Cell Lung Cancer, Uveal Melanoma
Phase 1CompletedOpna Bio LLC492017-09-122022-07-25

Conditions studied

Adenocarcinoma (1)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Genital Neoplasms, Female (1)  ·  Hematologic Neoplasms (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Multiple Myeloma (1)  ·  Myelodysplastic Syndromes (1)  ·  Ovarian Neoplasms (1)  ·  Prostatic Neoplasms (1)  ·  Small Cell Lung Carcinoma (1)  ·  Uveal Melanoma (1)

Interventions

Abiraterone Acetate (1)  ·  Carboplatin (1)  ·  Dexamethasone (1)  ·  Prednisone (1)  ·  olaparib (1)

Countries

United States (5)  ·  Canada (1)  ·  United Kingdom (1)